MedTrace Logo

Trehalose in Subjects With Neuronal Ceroid Lipofuscinoses

NCT04808297 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2022-04-11

No results posted yet for this study

Summary

Neuronal Ceroid Lipofuscinoses (NCL) or Batten's disease are the most common juvenile neurodegenerative disease, characterized by early blindness, movement disorders, cognitive and behavioral impairment, epilepsy, and retinopathy.

This study aims to collect clinical and laboratory data of patients with NCL taking Trehalose.

Conditions

  • Neuronal Ceroid-Lipofuscinoses

Sponsors & Collaborators

  • IRCCS Fondazione Stella Maris

    lead OTHER

Eligibility

Min Age
7 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2021-07-01
Completion
2021-10-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04808297 on ClinicalTrials.gov